Reconstitution of Natural Killer Cell Receptor Repertoires after Unmanipulated HLA-Mismatched/Haploidentical Blood and Marrow Transplantation: Analyses of CD94:NKG2A and Killer Immunoglobulin-Like Receptor Expression and Their Associations with Clinical Outcome
Authors:
Open Access
- 1 June 2007
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 13 (6) , 734-744
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prognosis after unmanipulated HLA‐haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipientsEuropean Journal of Haematology, 2007
- Deleterious effects of KIR ligand incompatibility on clinical outcomes in haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletionLeukemia, 2007
- The Effect of KIR Ligand Incompatibility on the Outcome of Unrelated Donor Transplantation: A Report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch RegistryTransplantation and Cellular Therapy, 2006
- Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donorsBlood, 2004
- The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor‐alloreactive T cells causing GVHDTissue Antigens, 2004
- T‐cell alloreactivity dominates natural killer cell alloreactivity in minimally T‐cell‐depleted HLA‐non‐identical paediatric bone marrow transplantationBritish Journal of Haematology, 2003
- Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donorsBlood, 2003
- Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplantsBlood, 2002
- Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effectBlood, 2002
- Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell TransplantationBlood, 1999